GeneralBullishBlockonomi · 3h ago6/10
📰
Revolution Medicines (RVMD) Stock Soars 20% on Breakthrough Pancreatic Cancer Trial Results
Revolution Medicines' stock surged 20% following positive Phase 3 trial results for daraxonrasib, a pancreatic cancer treatment that doubled survival rates to 13.2 months. The company is proceeding with FDA filing based on the breakthrough data.